Showing results (1541-1550 of 2,038) with videos related to
Sort By:
Pageof 204
Molecular Psychiatry|January 23, 2002
A family-based and case-control association study of the NOTCH4 gene and schizophreniaJ B Fan, J X Tang, N F Gu, et al.Oncogene|September 27, 2016
Cell cycle-coupled expansion of AR activity promotes cancer progressionC McNair, A Urbanucci, C E S Comstock, et al.Gut|October 24, 2009
Gut microbes define liver cancer risk in mice exposed to chemical and viral transgenic hepatocarcinogensJ G Fox, Y Feng, E J Theve, et al.European Urology Focus|July 30, 2017
Risk of Upgrading and Upstaging Among 10 000 Patients with Gleason 3+4 Favorable Intermediate-risk Prostate CancerDavid D Yang, Brandon A Mahal, Vinayak Muralidhar, et al.Molecular Cancer Research : MCR|July 18, 2014
The lncRNA PCAT29 inhibits oncogenic phenotypes in prostate cancerRohit Malik, Lalit Patel, John R Prensner, et al.Journal of Applied Crystallography|September 23, 2014
All-diamond optical assemblies for a beam-multiplexing X-ray monochromator at the Linac Coherent Light SourceS Stoupin, S A Terentyev, V D Blank, et al.Journal of the National Cancer Institute|July 10, 2026
Combining pathology artificial intelligence and genomic biomarkers to refine long-term postprostatectomy outcome predictionMatthew R Cooperberg, Kevin Shee, Janet E Cowan, et al.Plos Pathogens|November 21, 2012
Sensitivity of mitochondrial transcription and resistance of RNA polymerase II dependent nuclear transcription to antiviral ribonucleosidesJamie J Arnold, Suresh D Sharma, Joy Y Feng, et al.The Journal of Urology|February 28, 2016
Prognostic Value of Percent Gleason Grade 4 at Prostate Biopsy in Predicting Prostatectomy Pathology and RecurrenceAdam I Cole, Todd M Morgan, Daniel E Spratt, et al.European Urology|May 13, 2015
Characterization of 1577 primary prostate cancers reveals novel biological and clinicopathologic insights into molecular subtypesScott A Tomlins, Mohammed Alshalalfa, Elai Davicioni, et al.Pageof 204